ProCE Banner Series

Breathe Easy: Innovations and Expert Perspectives on the Management of Chronic Rhinosinusitis Without Nasal Polyps

Join us for a live webinar where national and local faculty will provide expert guidance on the management of chronic rhinosinusitis without nasal polyps, including diagnosis, the latest treatments, and tailoring care plans to individual patient needs.

  AAPA
  | AMA
  | ANCC
Who Should Attend

This program is intended for physicians, NPs, and PAs practicing in otolaryngology, allergy/immunology, and primary care. 

All Events

Breathe Easy: Innovations and Expert Perspectives on the Management of Chronic Rhinosinusitis Without Nasal Polyps

Upcoming Events

November

04

2024

8:00 AM - 9:00 AM Central Time (CT)

Virtual

CCO Simulcast | Host Group OK, Oklahoma City, Oklahoma

November

08

2024

7:00 AM - 8:00 AM Eastern Time (ET)

Virtual

CCO Simulcast | Host Group NC, Hendersonville, North Carolina

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of physicians, NPs, and PAs practicing in otolaryngology, allergy/immunology, and primary care in guideline-recommended diagnosis and management of patients with CRS without nasal polyps, including in their ability to appraise new therapies and novel delivery methods.

Target Audience
This program is intended for physicians, NPs, and PAs practicing in otolaryngology, allergy/immunology, and primary care. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Distinguish the diagnosis of CRSsNP from CRSwNP and other upper respiratory conditions

  • Assess available evidence for the management of CRSsNP, including novel delivery systems

  • Construct evidence-based, individualized treatment plans for patients with CRSsNP that incorporate both patient- and disease-associated considerations 

Accreditation

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by an educational grant from Optinose US, Inc.